Article
Levofloxacin 1.5% concentration combats ocular pathogens
Fort Lauderdale, FL-Topical levofloxacin 1.5% (Santen), a new concentration of the drug in clinical development, achieves tear-fluid concentrations well above the reported minimum inhibitory concentrations (MIC) for the most common ocular pathogens, reported Tom R. Walters, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
